[2-十七烷基-4,5-二氢-4-(羟基甲基)恶唑-4-基]甲基硬脂酸酯 | 20103-35-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: [2-十七烷基-4,5-二氢-4-(羟基甲基)恶唑-4-基]甲基硬脂酸酯
• 英文名称: [2-Heptadecyl-4,5-dihydro-4-(hydroxymethyl)oxazol-4-yl]methyl stearate
• 英文别名: [2-heptadecyl-4-(hydroxymethyl)-5H-1,3-oxazol-4-yl]methyl octadecanoate
• CAS: 20103-35-9
• 化学式: C₄₀H₇₇NO₄
• 分子量: 636.0
• InChiKey: DWWUGXOZBYVGJN-UHFFFAOYSA-N

物化性质

• 沸点：
  675.7±20.0 °C(Predicted)
• 密度：
  0.95±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  15.7
• 重原子数：
  45
• 可旋转键数：
  36
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  68.1
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• SOLID PHASE CHANGE INK COMPOSITIONS COMPRISING OXAZOLINES
  申请人：Carlini Rina

  公开号：US20130032057A1

  公开（公告）日：2013-02-07

  A solid ink composition comprising at least one crystalline oxazoline compound and at least one amorphous component derived from a polyol, and a colorant and optional viscosity modifier, which are suitable for inkjet printing, including printing on coated paper substrates. In embodiments, the solid ink formulation comprises a blend of an amorphous and crystalline components which provides a solid ink with excellent robustness when forming images or printing on coated paper substrates.

  一种固体油墨组合物，包括至少一种结晶的噁唑啉化合物和至少一种来自多元醇的非晶组分，以及一种色料和可选的粘度调节剂，适用于喷墨打印，包括在涂层纸基底上打印。在实施例中，固体油墨配方包括非晶和结晶组分的混合物，提供具有卓越韧性的固体油墨，用于形成图像或在涂层纸基底上打印。
• Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
  申请人：N30 Pharmaceuticals, Inc.

  公开号：US20140194481A1

  公开（公告）日：2014-07-10

  The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

  本发明涉及S-亚硝基谷胱甘肽还原酶（GSNOR）的抑制剂，包括这些GSNOR抑制剂的制药组合物以及制备和使用它们的方法。
• INK COMPOSITIONS INCORPORATING SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES
  申请人：CARLINI Rina

  公开号：US20120274710A1

  公开（公告）日：2012-11-01

  An ink composition including one or more oxazoline compounds or oxazoline derivatives having either crystalline, amorphous or even semi-crystalline properties for use in a particular printing application, such as in a direct-to-paper print process.
• Phase Separation Ink
  申请人：Odell Peter G.

  公开号：US20120274713A1

  公开（公告）日：2012-11-01

  A phase separation ink including at least one crystallizable component that crystallizes as it cools from a first ink jetting temperature to a second lower temperature; at least one amorphous component comprising a material that remains amorphous at the second temperature; an optional colorant; wherein the at least one crystallizable component and the at least one amorphous component are in a molten, single phase state at the first ink jetting temperature; wherein at the second temperature, the phase separation ink comprises a crystalline phase comprising the at least one crystallizable component and an amorphous phase comprising the at least one amorphous component; wherein the amorphous phase of the at least one phase separation ink substantially penetrates into the final image receiving substrate and the crystalline phase of the at least one phase separation ink substantially remains on the surface of the final image receiving substrate.
• SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES
  申请人：CARLINI Rina

  公开号：US20120272859A1

  公开（公告）日：2012-11-01

  Substituted oxazoline compounds and/or substituted oxazoline derivatives having amorphous, semi-crystalline, or crystalline properties and methods for producing such compounds and derivatives are presented. The substituted oxazoline compounds and/or substituted oxazoline derivatives are useful for various applications. For example, the substituted oxazoline compounds and/or substituted oxazoline derivatives may function as phase-change agents, a binder resins, rheology modifiers or plasticizers for ink compositions.